Search research articles
Contact Us
Filters
Showing results (411-420 of 428) with videos related to
Page
of 43
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Cancer Discovery
|
October 1, 2025
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal Expansion
Divij Verma, Rachel Zeig-Owens, David G Goldfarb, et al.
Nature Medicine
|
March 8, 2022
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster
Sakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, et al.
Cancer Research
|
June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Rafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Research Square
|
May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma
Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
The New England Journal of Medicine
|
September 28, 2022
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2022
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, et al.
JAMA Oncology
|
April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial
Ola Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Blood Cancer Journal
|
May 18, 2021
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, et al.
Page
of 43
Search research articles
Search
Showing results (411-420 of 428) with videos related to
Sort By:
Page
of 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Cancer Discovery
|
October 1, 2025
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal Expansion
Divij Verma, Rachel Zeig-Owens, David G Goldfarb, et al.
Nature Medicine
|
March 8, 2022
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster
Sakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, et al.
Cancer Research
|
June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Rafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Research Square
|
May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma
Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
The New England Journal of Medicine
|
September 28, 2022
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2022
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, et al.
JAMA Oncology
|
April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial
Ola Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Blood Cancer Journal
|
May 18, 2021
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, et al.
Page
of 43